158 related articles for article (PubMed ID: 15723259)
1. Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.
Fishel ML; Gamcsik MP; Delaney SM; Zuhowski EG; Maher VM; Karrison T; Moschel RC; Egorin MJ; Dolan ME
Cancer Chemother Pharmacol; 2005 Apr; 55(4):333-342. PubMed ID: 15723259
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.
Rabik CA; Fishel ML; Holleran JL; Kasza K; Kelley MR; Egorin MJ; Dolan ME
J Pharmacol Exp Ther; 2008 Nov; 327(2):442-52. PubMed ID: 18664592
[TBL] [Abstract][Full Text] [Related]
3. Role of GADD34 in modulation of cisplatin cytotoxicity.
Fishel ML; Rabik CA; Bleibel WK; Li X; Moschel RC; Dolan ME
Biochem Pharmacol; 2006 Jan; 71(3):239-47. PubMed ID: 16325149
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.
Fishel ML; Delaney SM; Friesen LD; Hansen RJ; Zuhowski EG; Moschel RC; Egorin MJ; Dolan ME
Mol Cancer Ther; 2003 Jul; 2(7):633-40. PubMed ID: 12883036
[TBL] [Abstract][Full Text] [Related]
5. Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity.
Fishel ML; Newell DR; Griffin RJ; Davison R; Wang LZ; Curtin NJ; Zuhowski EG; Kasza K; Egorin MJ; Moschel RC; Dolan ME
J Pharmacol Exp Ther; 2005 Jan; 312(1):206-13. PubMed ID: 15304523
[TBL] [Abstract][Full Text] [Related]
6. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
7. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Peters RH; Jollow DJ; Stuart RK
Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
Pendyala L; Perez R; Weinstein A; Zdanowicz J; Creaven PJ
Cancer Chemother Pharmacol; 1997; 40(1):38-44. PubMed ID: 9137527
[TBL] [Abstract][Full Text] [Related]
9. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
[TBL] [Abstract][Full Text] [Related]
10. Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.
Yang Z; Faustino PJ; Andrews PA; Monastra R; Rasmussen AA; Ellison CD; Cullen KJ
Cancer Chemother Pharmacol; 2000; 46(4):255-62. PubMed ID: 11052622
[TBL] [Abstract][Full Text] [Related]
11. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
[TBL] [Abstract][Full Text] [Related]
12. Cell line-dependent difference in glutathione levels affects the cigarette sidestream smoke-induced inhibition of nucleotide excision repair.
Yamashita R; Komaki Y; Yang G; Ibuki Y
Mutat Res Genet Toxicol Environ Mutagen; 2020; 858-860():503273. PubMed ID: 33198939
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms.
Zhang K; Chew M; Yang EB; Wong KP; Mack P
Mol Pharmacol; 2001 Apr; 59(4):837-43. PubMed ID: 11259628
[TBL] [Abstract][Full Text] [Related]
14. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
[TBL] [Abstract][Full Text] [Related]
15. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
Shellard SA; Hosking LK; Hill BT
Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
[TBL] [Abstract][Full Text] [Related]
16. Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines.
Iida M; Doi H; Asamoto S; Sugiyama H; Sakagami H; Kuribayashi N; Takeda M; Okamura Y; Matsumoto K
Anticancer Res; 1999; 19(6B):5383-4. PubMed ID: 10697565
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression.
Passagne I; Evrard A; Winum JY; Depeille P; Cuq P; Montero JL; Cupissol D; Vian L
J Pharmacol Exp Ther; 2003 Nov; 307(2):816-23. PubMed ID: 12970393
[TBL] [Abstract][Full Text] [Related]
18. Role of copper transporters in resistance to platinating agents.
Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME
Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134
[TBL] [Abstract][Full Text] [Related]
19. Role of O6-methylguanine-DNA methyltransferase, glutathione transferase M3-3 and glutathione in resistance to carmustine in a human non-small cell lung cancer cell line.
Egyházi S; Edgren MR; Hansson J; Kröckel D; Mannervik B; Ringborg U
Eur J Cancer; 1997 Mar; 33(3):447-52. PubMed ID: 9155531
[TBL] [Abstract][Full Text] [Related]
20. Intracellular glutathione and cytotoxicity of platinum complexes.
Pendyala L; Creaven PJ; Perez R; Zdanowicz JR; Raghavan D
Cancer Chemother Pharmacol; 1995; 36(4):271-8. PubMed ID: 7628045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]